Taimei Tech Buys Back 60,000 H-Shares, Lifting Treasury Stock to 10.41 Million

Bulletin Express10-14

Zhejiang Taimei Medical Technology Co., Ltd. (Taimei Tech) reported the repurchase of 60,000 H-shares on 14 October 2026, according to its Next Day Disclosure Return filed with the Hong Kong Stock Exchange.

The on-market buyback was executed at prices between HKD 4.325 and HKD 4.62 per share, yielding a volume-weighted average cost of HKD 4.3991. Total consideration amounted to HKD 0.26 million.

Following the transaction, Taimei Tech’s issued share capital (excluding treasury shares) declined by 0.03% to 190.18 million shares. Treasury shares rose to 10.41 million, while the company’s total issued shares remained unchanged at 200.59 million.

The repurchase forms part of the mandate approved on 23 June 2026, which authorises the company to buy back up to 20.02 million shares. Cumulative repurchases under this mandate now stand at 9.99 million shares, representing 4.99% of the total issued shares outstanding on the mandate date.

Under Hong Kong listing rules, Taimei Tech is subject to a moratorium on issuing new shares or disposing of treasury shares until 13 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment